Morgs
banner
morgs6942.bsky.social
Morgs
@morgs6942.bsky.social
ME/CFS since Sept 92.
Reposted by Morgs
1) The European Commission has several funding opportunities for NGO’s, which might also be relevant for ME/CFS organizations.

We wanted to share some of these programs.
commission.europa.eu/funding-tend...
Funding opportunities for NGOs
NGOs can benefit from a number of funding opportunities.
commission.europa.eu
July 4, 2025 at 8:23 AM
Reposted by Morgs
Healthspan: 'The Mitochondrial Signature of Long COVID: What PRDX3 Is Trying to Tell Us—And How We Might Reverse It'

'One of the most compelling new biomarkers...is peroxiredoxin-3 (PRDX3), a mitochondrial antioxidant enzyme found at elevated levels..'

gethealthspan.com/science/arti...
Healthspan Research Review | The Mitochondrial Signature of Long COVID: What PRDX3 Is Trying to Tell Us—And How We Might Reverse It
Long COVID presents with a complex constellation of persistent symptoms—fatigue, brain fog, muscle weakness—that often occur despite unremarkable findings on conventional tests. Emerging evidence sugg...
gethealthspan.com
June 2, 2025 at 2:03 AM
Reposted by Morgs
Exciting new ME/CFS research by Prof. Klaus Wirth.

youtu.be/6FkenaYkz3c?...
The Man Trying to Cure ME/CFS & Long Covid: Prof. Klaus Wirth on Mitodicure
YouTube video by Understanding ME-CFS
youtu.be
May 15, 2025 at 5:04 AM
Reposted by Morgs
Hisar, India researchers show that SB431542, a TGF-β inhibitor, blocks SARS-CoV-2 by targeting three steps at once—entry, assembly, and release.

No resistance emerged after 50 viral generations, making it a promising broad-spectrum antiviral.

www.biorxiv.org/content/10.1...
TGF-β inhibitor SB431542 suppresses coronavirus replication through multistep inhibition
The COVID-19 pandemic highlighted the critical need for broad-spectrum antivirals with high resistance barriers. Here, we demonstrate that SB431542, a selective TGF-β receptor I (ALK5) inhibitor, exhi...
www.biorxiv.org
March 22, 2025 at 1:14 PM
Reposted by Morgs
March 11, 2025 at 5:00 AM
Reposted by Morgs
Researchers found that IL6 suppresses mitochondrial function via the JAK1/STAT1/3-HIF1α/ERRα pathway.

When PGC1 levels are low, IL6 stabilizes HIF1α, which inhibits ERRα, reducing mitochondrial activity.

Boosting PGC1 reverses this effect.

www.cell.com/cell-reports...
The pro-inflammatory cytokine IL6 suppresses mitochondrial function via the gp130-JAK1/STAT1/3-HIF1α/ERRα axis
Xu et al. show that IL6, not TNF-α, suppresses mitochondrial function. When PGC1 is low, IL6 increases HIF1A transcription and stabilizes HIF1α protein via ERRα. HIF1α reciprocally suppresses ERRα, co...
www.cell.com
March 8, 2025 at 12:25 AM
Reposted by Morgs
🔬 𝗟𝗮𝗻𝗱𝗺𝗮𝗿𝗸 𝗟𝗼𝗻𝗴 𝗖𝗢𝗩𝗜𝗗 𝗦𝘁𝘂𝗱𝘆 𝗖𝗼𝗻𝗳𝗶𝗿𝗺𝘀 𝗞𝗲𝘆 𝗚𝗲𝗻𝗲𝘁𝗶𝗰 𝗔𝘀𝘀𝗼𝗰𝗶𝗮𝘁𝗶𝗼𝗻𝘀 𝗔𝗰𝗿𝗼𝘀𝘀 𝗗𝗶𝘃𝗲𝗿𝘀𝗲 𝗣𝗼𝗽𝘂𝗹𝗮𝘁𝗶𝗼𝗻𝘀: 𝗣𝗮𝘃𝗶𝗻𝗴 𝘁𝗵𝗲 𝗪𝗮𝘆 𝗳𝗼𝗿 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 & 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁𝘀

We’re excited to share a major breakthrough in 𝗹𝗼𝗻𝗴 𝗖𝗢𝗩𝗜𝗗 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵.

🔍 Read the full press release: precisionlife.com/news-and-eve...
February 26, 2025 at 3:23 PM
Reposted by Morgs
Accelerate research & care for #MECFS and #LongCOVID

Renegade Research (RR) is a non-profit 501c3 decentralized organization pioneering #patient & #caregiver led #research with a focus on ME/CFS, Long COVID (LC) & other infection associated chronic illnesses #IACI...

www.zeffy.com/en-US/fundra...
Accelerate research and care for ME/CFS & Long COVID
Renegade Research (RR) is a non-profit, 501c3 decentralized organization pioneering patient and caregiver-led research with a focus on ME/CFS, Long COVID (LC) and other infection associated chronic il...
www.zeffy.com
February 28, 2025 at 9:17 AM
Reposted by Morgs
New US poster abstract from a long-term ME/CFS expert, John Chia:

Efficacy Of SARS–CoV-2 Specific Antiviral Therapy for Enteroviral Myalgic Encephalomyelitis/ChronicFatigue Syndrome

academic.oup.com/ofid/article...

#MEcfs #CFS
February 1, 2025 at 12:25 AM
Reposted by Morgs
This is from a summary of the Ciba Foundation conference in May 1992 of Sharpe's chapter presentation and the discussion that followed.

His trial reported "an unexpectedly high rate of improvement in the comparison [treatment as usual] group."
"Non pharmaceutical treatment of CFS"
"Sharpe admits there was no scientific foundation for his promotion of CBT as a treatment for #ME #MEcfs
Ignoring all evidence of pathology, he aimed to merely change the beliefs of #pwME.
It was hidden away as part of the 'Secret Files'."
👇
January 28, 2025 at 6:16 PM
Reposted by Morgs
In this project, they developed an algorithm that can identify ME/CFS from a panel of metabolic markers and survey data with good specificity.

Read more about this study👉 ow.ly/Hker50UL3zJ.
Discriminating ME/CFS and Comorbid Conditions Using NMR Metabolomics in UK Biobank - Open Medicine Foundation
Explore new publication from the OMF Melbourne ME/CFS Collaboration: Discriminating ME/CFS and Comorbid Conditions Using NMR Metabolomics in UK Biobank.
ow.ly
January 22, 2025 at 3:14 PM